Lucia Romani Selected Research

Scabies (Sarcoptic Mange)

9/2022	Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.
5/2022	Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.
1/2022	Costs of mass drug administration for scabies in Fiji.
11/2021	Community control strategies for scabies: A cluster randomised noninferiority trial.
1/2021	Recent advances in understanding and treating scabies.
1/2021	A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
12/2020	Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
12/2020	Community perspectives on scabies, impetigo and mass drug administration in Fiji: A qualitative study.
10/2020	Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
1/2020	Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Romani Research Topics

Disease

20	Scabies (Sarcoptic Mange) 09/2022 - 06/2014
8	Impetigo (Impetigo Contagiosa) 09/2022 - 12/2015
6	Filarial Elephantiasis (Lymphatic Filariasis) 05/2022 - 01/2020
5	Neglected Diseases 01/2022 - 10/2018
2	Infections 05/2022 - 01/2021
2	Trachoma 01/2019 - 10/2018
1	Soft Tissue Infections 05/2022
1	Larva Migrans (Cutaneous Larva Migrans) 01/2021
1	Myiasis (Myiases) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Reinfection 01/2021
1	Strongyloidiasis 01/2021
1	Trichuriasis 01/2021
1	Furunculosis (Boils) 01/2019
1	Abscess 01/2019
1	type 3 Lamellar ichthyosis 12/2014

Drug/Important Bio-Agent (IBA)

14	Ivermectin (Mectizan)FDA Link 05/2022 - 06/2014
5	Albendazole (Albenza)FDA Link 05/2022 - 01/2020
5	Diethylcarbamazine (Hetrazan)FDA Link 05/2022 - 01/2020
4	Permethrin (Ambush)FDA LinkGeneric 05/2022 - 12/2015
4	Azithromycin (Zithromax)FDA LinkGeneric 10/2020 - 10/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2018
1	insulin receptor-related receptor (IRR)IBA 05/2022
1	P-30 composite resin (P 30)IBA 01/2021
1	AntibodiesIBA 12/2020
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2018
1	EnzymesIBA 12/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2014
1	benzyl benzoate (Ansar)FDA Link 06/2014

Therapy/Procedure

23	Mass Drug Administration 09/2022 - 06/2014
2	Drug Therapy (Chemotherapy) 03/2022 - 01/2020
1	Therapeutics 06/2014